Sheila Bush holds a photo of herself during her cancer treatment. REUTERS/Lawrence Bryant
|
More than 7,000 lawsuits in the U.S. allege at least a dozen cosmetic companies, including L’Oréal and Revlon, sold hair relaxers containing chemicals that increased the risk of developing uterine cancer, and failed to warn customers.
A U.S. National Institutes of Health study last October found an association, though not a causal link, between frequent use of relaxers and uterine cancer. The companies deny the allegations and have asked a judge to dismiss the cases, which face various legal hurdles. Read more.
|
A new 3rd Circuit decision addressing fee awards for class action lawyers asks a piquant math question: If a trial judge opts to calculate fees based on a percentage of the class fund, should that percentage be based on the total size of the fund available to class members? Or should lawyers for the class receive only a percentage of the money actually paid out to class members? Alison Frankel examines how the 3rd Circuit answered those questions. Spoiler alert: It’s complicated.
Check out other recent pieces from all our columnists: Alison Frankel, Jenna Greene and Hassan Kanu
|